Several signal pathways driving vascular abnormality in GBM have been uncovered, including hypoxia, transforming growth factor β (TGFβ), pleiotrophin (PTN) and vascular endothelial growth factor (VEGF) signaling pathways (9–12). This evidence concerns the gene TGFB1 and glioblastoma.